ATE14837T1 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number
ATE14837T1
ATE14837T1 AT81902743T AT81902743T ATE14837T1 AT E14837 T1 ATE14837 T1 AT E14837T1 AT 81902743 T AT81902743 T AT 81902743T AT 81902743 T AT81902743 T AT 81902743T AT E14837 T1 ATE14837 T1 AT E14837T1
Authority
AT
Austria
Prior art keywords
drug
folic acid
pharmaceutical compositions
depressant
pharmaceutical composition
Prior art date
Application number
AT81902743T
Other languages
English (en)
Inventor
Alec James Coppen
Original Assignee
Alec James Coppen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alec James Coppen filed Critical Alec James Coppen
Application granted granted Critical
Publication of ATE14837T1 publication Critical patent/ATE14837T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT81902743T 1981-10-05 1981-10-05 Pharmazeutische zusammensetzungen. ATE14837T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB1981/000218 WO1983001199A1 (en) 1981-10-05 1981-10-05 Pharmaceutical compositions
EP81902743A EP0089948B1 (de) 1981-10-05 1981-10-05 Pharmazeutische zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE14837T1 true ATE14837T1 (de) 1985-08-15

Family

ID=10518816

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81902743T ATE14837T1 (de) 1981-10-05 1981-10-05 Pharmazeutische zusammensetzungen.

Country Status (4)

Country Link
EP (1) EP0089948B1 (de)
AT (1) ATE14837T1 (de)
DE (1) DE3171821D1 (de)
WO (1) WO1983001199A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1071425T3 (da) * 1998-04-24 2007-12-27 Scarista Ltd Behandling af depression og farmaceutiske præparater dertil

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE739613A (de) * 1968-10-03 1970-03-02
GB2072504B (en) * 1980-03-27 1983-10-26 Coppen A J Pharmaceutical compositions

Also Published As

Publication number Publication date
EP0089948B1 (de) 1985-08-14
WO1983001199A1 (en) 1983-04-14
DE3171821D1 (en) 1985-09-19
EP0089948A1 (de) 1983-10-05

Similar Documents

Publication Publication Date Title
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
MY101791A (en) New benzimidazole derivatives
ATE427103T1 (de) Orale verabreichung von adenosin analogen
MY101784A (en) Novel pharmacological compounds
NZ244021A (en) Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
ES8608864A1 (es) Un procedimiento para producir un preparado a modo de hojas
SE8700498D0 (sv) Novel pharmaceologically active compounds
ES431675A1 (es) Un procedimiento para preparar compuestos de hexahidro-di- benzo(b,d) piran-9-ona.
ES8307744A1 (es) Un metodo para la preparacion de nuevos derivados de sales de metales alcalinos de acidos 2-pirrolidon-4-carboxilicos.
ES2110212T3 (es) Composicion farmaceutica efervescente que contiene ibuprofeno y su procedimiento de preparacion.
GB1418208A (en) Pharmaceutical compositions
SE8405588D0 (sv) New compounds
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
ES8705763A1 (es) Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos
SE8600658D0 (sv) Novel composition of matter
MY102411A (en) Nasal solutions
KR890004705A (ko) 항바이러스성 제제
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
ATE14837T1 (de) Pharmazeutische zusammensetzungen.
MY100780A (en) Azumolene dosage form.
MY101821A (en) Quinazolinediones and pyridopyrimidinediones
JO1531B1 (en) New near-compounds
MY102368A (en) Solid sustained-release composition
GB1454872A (en) Anticonvulsant

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee